11 October 2018KeynoteJules A. Hoffmann, Nobel Prize in Physiology or Medicine 2011, Professor at University of Strasbourg for Advanced Study, Chair of Integrative BiologyWhat do translational medicine and patients' association expect from research?Ulf Nehrbass, CEO, Luxembourg Institute of HealthMary Baker, Immediate Past President, European Federation of Neurological Associations and European Brain CouncilGenetics in Parkinson's disease - are we ready for the next step?Karl Kieburtz, Professor of Neurology, University of RochesterLena Burbulla, Research Assistant Professor, Department of Neurology, Feinberg School of Medicine Northwestern UniversityThomas Gasser, Director, Department of Neurodegenerative Diseases and Professor of Neurology, Hertie-Institute for Clinical Brain Research, Center of Neurology, University of TübingenSean Sapcariu, Programme Manager, Luxembourg National Research FundNew strategies to prevent neurodegenerationChristine von Arnim, Professor of Neurology, Ulm UniversityAnja Schneider, Director, Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Clinic Bonn and group leader at German Center for Neurodegenerative DiseasesRussell Swerdlow, Director, University of Kansas Alzheimer’s Disease CenterSmart devices and sensor-based technologiesJochen Klucken, Vice Head, Department of Molecular Neurology at the University Hospital Erlangen, Friedrich-Alexander University Erlangen-NürnbergJens Clausen, Head of Department Ethics and Lifesciences and their Didactics, University of Education, FreiburgLara Mangravite, President, Sage BionetworksSocial Event12 October 2018KeynoteCaroline M Tanner, Professor, Department of Neurology, University of California School of Medicine, San FranciscoIs Parkinson's disease ready for precision medicine?Nobutaka Hattori, Professor and Chairman, Department of Neurology, Juntendo UniversityRonan T. Fleming, Assistant Professor, Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden UniversityOlga Corti, Research Director, French National Institute of Health and Medical Research (Inserm)Cohorts as test bedsWolfgang Oertel, Hertie-Senior-Research-Professor, Department of Neurology, Philipps University MarburgAlastair Noyce, Clinical Senior Lecturer in Preventive Neurology,Queen Mary University of LondonPaul Wilmes, Principal Investigator, Luxembourg Centre for Systems Biomedicine, University of LuxembourgMultidisciplinary approach to PD carePille Taba, Professor of Neurology, University of TartuElke Kalbe, Head of Department Medical Psychology, University Clinic CologneMariella Graziano, President of the Association of Physiotherapists in Parkinson ’s disease EuropeGrit Mallien, speechtherapist and practice owner, Doktor Logo